Publicaciones en colaboración con investigadores/as de Universidad Camilo José Cela (31)

2024

  1. ApTOLL: A new therapeutic aptamer for cytoprotection and (re)myelination after multiple sclerosis

    British Journal of Pharmacology, Vol. 181, Núm. 17, pp. 3263-3281

2023

  1. Melatonin as Modulator for Sulfur and Nitrogen Mustard-Induced Inflammation, Oxidative Stress and DNA Damage: Molecular Therapeutics

    Antioxidants, Vol. 12, Núm. 2

  2. Non-Excitatory Amino Acids, Melatonin, and Free Radicals: Examining the Role in Stroke and Aging

    Antioxidants, Vol. 12, Núm. 10

  3. POTENTIAL OF MELATONIN TO REVERSE EPIGENETIC ABERRATIONS IN ORAL CANCER: NEW FINDINGS

    EXCLI Journal, Vol. 22, pp. 1280-1310

  4. Redox Regulation of Microglial Inflammatory Response: Fine Control of NLRP3 Inflammasome through Nrf2 and NOX4

    Antioxidants, Vol. 12, Núm. 9

  5. Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review

    Pharmaceutics, Vol. 15, Núm. 6

2022

  1. Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies

    Frontiers in Pharmacology, Vol. 13

  2. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 3, pp. 489-500

  3. Editorial: Therapeutic Advances in Melatonin Research

    Frontiers in Pharmacology

2021

  1. The coronavirus disease 2019 (Covid-19): Key emphasis on melatonin safety and therapeutic efficacy

    Antioxidants, Vol. 10, Núm. 7

  2. Toxicology of Blister Agents: Is Melatonin a Potential Therapeutic Option?

    DISEASES, Vol. 9, Núm. 2

2020

  1. Cerebral ischemia and traumatic brain injury: Protection by melatonin

    Melatonin: Production, Functions and Benefits (Nova Science Publishers, Inc.), pp. 231-255

  2. Detection of neurological and ophthalmological pathologies with optical coherence tomography using retinal thickness measurements: A bibliometric study

    Applied Sciences (Switzerland), Vol. 10, Núm. 16

  3. In Vitro and in Silico ADME-Tox Profiling and Safety Significance of Multifunctional Monoamine Oxidase Inhibitors Targeting Neurodegenerative Diseases

    ACS Chemical Neuroscience, Vol. 11, Núm. 22, pp. 3793-3801

  4. Melatonin reduces NLRP3 inflammasome activation by increasing α7 nAChR-mediated autophagic flux

    Antioxidants, Vol. 9, Núm. 12, pp. 1-18

  5. Melatonin's efficacy in stroke patients; a matter of dose? A systematic review

    Toxicology and Applied Pharmacology, Vol. 392

  6. Scientific production on melatonin from a bibliometric perspective

    Melatonin: Production, Functions and Benefits (Nova Science Publishers, Inc.), pp. 1-17

  7. Understanding the oncostatic actions displayed by melatonin in colorectal cancer therapy

    Future Medicinal Chemistry, Vol. 12, Núm. 13, pp. 1201-1204

2019

  1. Potential of melatonin as adjuvant therapy of oral cancer in the era of epigenomics

    Cancers, Vol. 11, Núm. 11

2018

  1. A history of the pharmacological treatment of bipolar disorder

    International Journal of Molecular Sciences, Vol. 19, Núm. 7